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Although hyperventilation syndrome generally carries a good prognosis, it is associated with the risk of developing
severe symptoms, such as post-hyperventilation apnea with hypoxemia and loss of consciousness. We experienced
a patient who suffered from post-hyperventilation apnea. A 17-year-old female who suffered from hyperventilation
syndrome for several years developed post-hyperventilation apnea after treatment using the paper bag rebreathing
method and sedative administration during a dental procedure. We subsequently successfully provided her with
monitored anesthesia care with propofol. Monitored anesthesia care with propofol may be effective for the general
management of patients who have severe hyperventilation attacks and post-hyperventilation apnea. This case
demonstrates that appropriate emergency treatment should be available for patients with hyperventilation attacks
who are at risk of developing post-hyperventilation apnea associated with hypoxemia and loss of consciousness.
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Hyperventilation syndrome in patients with no under-
lying organic abnormality is frequently observed during
medical and dental practice. Although the pathophysio-
logical mechanisms of hyperventilation syndrome are
still not fully understood, the relative roles of peripheral
and central chemoreceptors in causing hyperventilation
attacks have been suggested. Although it is believed that
episodes of hyperventilation attacks resolve spontan-
eously and that the paper-bag rebreathing method or ad-
ministration of anxiolytic agents may help mitigate an
attack, sustained symptoms associated with hypocapnia
have been reported to initiate complex clinical complica-
tions, such as the delayed occurrence of hypoxemia.
Furthermore, several case reports have described the occur-
rence of post-hyperventilation apnea in association with
sustained cyanosis, hypoxemia and loss of consciousness
[1-4]. The pathogenesis of post-hyperventilation apnea has* Correspondence: ayuse@nagasaki-u.ac.jp
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unless otherwise stated.been linked to the activity of peripheral chemoreceptors,
which may contribute to the susceptibility to apnea during
hypoxia or hyperoxia [5]. We provided monitored anesthesia
care thrice to a patient who had a history of hyperventila-
tion attacks and post-hyperventilation apnea during dental
treatment under sedation with regional anesthesia. The
aim of this report is to describe the management of hyper-
ventilation attacks and post-hyperventilation apnea during
dental treatment.Case presentation
First episode (Figure 1)
A female 17-year-old (height 154 cm, weight 56.4 kg)
was scheduled for dental treatment (root canal treatment
for an infected lower second molar) under regional
anesthesia at the dental office of a university hospital.
Since she had previously experienced hyperventilation
attacks, not only during dental treatment but also in
other situations, such as during bus rides, she was pre-
scribed benzodiazepines (alprazolam) and paroxetine
hydrochloride hydrate by a psychiatrist for a diagnosis of
hyperventilation syndrome. There was no other medical
history other than the psychological aspects. During the
root canal treatment, the patient had a hyperventilationral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Time course of the first episode. Midazolam was used for the treatment of hyperventilation syndrome.
Kobayashi et al. BioPsychoSocial Medicine 2014, 14:26 Page 2 of 5
http://www.bpsmedicine.com/content/14/1/26attack after experiencing pain. After fifteen minutes of
therapeutic treatment using the rebreathing method with
a paper bag did not alleviate her symptoms, our team
dental anesthesiologist was asked to support her respira-
tory condition. As shown in Figure 1, after confirming
sustained hyperventilation of respiratory rate 50 ~ 60
breaths/minute with desaturation to 92% associated with
blood pressure 130/83 mmHg and pulse rate 115 beats/
minute, we decided to provide low dose 2 l/min of oxy-
gen supplementation using a bag-valve-mask instead of
using the paper bag. With this, although her oxygen sat-
uration improved to 100%, hyperventilation continued
for 20 minutes. Confirming sustained hyperventilation,
we decided to administer midazolam intravenously, as
generally recommended in the treatment algorithm for
hyperventilation syndrome [6]. However, we decided to
decrease the dose of intravenous administration of mid-
azolam to 0.5 mg, to minimize the risk of unpredictable
changes in respiratory function. Immediately after injec-
tion of midazolam the hyperventilation subsided, with her
respiratory rate improving to 20 breaths/minute. However,
she then lost consciousness and developed complete
apnea, resulting in significant desaturation to 88 ~ 76%.
We tried to treat her with artificial ventilation using a
bag-valve-mask with supplementation of a higher dose of
5 ~ 7 l/min oxygen. Two minutes after continuous mask
ventilation of 8 ~ 10 counts/min to treat the complete
apnea associated with unconsciousness and cyanosis, she
regained consciousness and began to breathe at a respira-
tory rate of 15 breaths/minute. Her blood pressure was120/80 mmHg and pulse rate was 72 beats/minute. We
continuously monitored her respiratory condition for
ne hour until full recovery from the symptoms. There-
after, we informed the patient and her mother about the
episode of severe hyperventilation attack and post-
hyperventilation apnea during the dental treatment
and recommended that she undergo further such treat-
ments under monitored anesthesia, care with spontan-
eous breathing.
Second episode (Figure 2)
Several weeks later, the same patient was scheduled for
dental treatment under monitored anesthesia care with
spontaneous breathing plus regional anesthesia. We in-
duced and maintained anesthesia for one hour with a
target controlled infusion of propofol (TCI level = 1.1 ~
1.2 μg/ml) after intravenous administration of 1 mg mid-
azolam. At the end of treatment, propofol was discontin-
ued and the patient was carefully observed by the
anesthesiologist until return of consciousness. Although
she regained consciousness 20 minutes after stopping the
propofol infusion, hyperventilation with a respiratory rate
of 40 breaths/minute occurred and continued for several
minutes. Immediately after the hyperventilation subsided
spontaneously, post-hyperventilation apnea with desatur-
ation to 86% occurred in association with loss of con-
sciousness. However, the patient regained consciousness
within one minute without any therapeutic intervention.
She was discharged after confirming full recovery from
the unstable respiratory condition.
Figure 2 Time course of the second episode. Propofol anesthesia after midazolam premedication was used for general management.
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The patient was scheduled for the third dental treat-
ment session under monitored anesthesia care with
spontaneous breathing plus regional anesthesia. As with
the previous anesthetic management, we induced with-
out any premedication and maintained anesthesia with a
TCI of propofol (TCI level = 1.2 ~ 1.5 μg/ml) for the fifty
minute treatment period. At the end of the treatment,
propofol was discontinued and the anesthesiologist care-
fully observed the patient until recovery of consciousness.
She did not develop any symptoms of hyperventilation,Figure 3 Time course of the third episode. Propofol was used for genereven 10 minutes after regaining consciousness and was
later discharged after an uneventful recovery period.
Discussion
It is known that some patients with hyperventilation syn-
drome develop post-hyperventilation apnea or hypoxia
with cyanosis and loss of consciousness, resulting in severe
complications, including death [7,8]. The pathogenesis of
post-hyperventilation apnea has only been partly under-
stood as being due to the activity of peripheral chemore-
ceptors that may contribute to the susceptibility to apneaal management.
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suggested that apnea secondary to hyperventilation occurs
because following the wash out of carbon dioxide from
the body during hyperventilation an extended period of
time is required for it to accumulate adequately enough to
reach the threshold required to stimulate breathing [10].
In our patient, because oxygen continued to be supplied
during artificial respiration with bag-valve-mask, even
after the hyperventilation diminished, the patient probably
had a low PaCO2 and high PaO2. In such a situation, the
imbalance in the levels of both PaO2 and PaCO2 would
have resulted in the peripheral chemoreceptors initiating a
compensatory apnea reaction until sufficient carbon dioxide
accumulated to reach the threshold to stimulate adequate
breathing. Although, usually, a vicarious arousal reaction to
the apnea can occur, in this case this arousal reaction was
probably inhibited by the sedative effect of the small dose
of midazolam used in first episode and second episodes.
It has also been suggested that administration of benzo-
diazepine drugs, such as diazepam or midazolam, may
contribute to increasing the threshold for respiratory
stimulation. In other words, reduction of respiratory con-
trol related to the sedative effects of drugs might decrease
the respiratory stimulant effect of arterial carbon dioxide
wash out [11]. They suggest that 5-hydroxytryptamine 1A
agonists can provide adequate anxiolysis in patients who
have frequent occurrence of post-hyperventilation apnea.
These studies indicate that the drugs used to manage and
treat patients with hyperventilation syndrome should be
carefully chosen, due to the risk of occurrence of post-
hyperventilation apnea. In our case, we used midazolam
followed by propofol, a short acting intravenous anesthetic
agent, during the second episode. However, when we did
not use midazolam in the third episode, there were
no symptoms of post-hyperventilation apnea after propo-
fol anesthesia. We cannot deny that the small dose
of midazolam administered may have caused the post-
hyperventilation apnea due to its sedative effect. However,
it is difficult to believe that the effects of 1 mg administra-
tion of midazolam would remain active for the 1 hour
20 minutes before the emergence of post-hyperventilation
apnea. The exact influence of propofol on the occurrence
of post-hyperventilation apnea is not known. Previously,
Tomioka et al. reported that propofol was not effective in
preventing hyperventilation syndrome [12]. However, based
on the third episode in our patient, in which she regained
consciousness from propofol anesthesia without any symp-
toms of hyperventilation and/or post-hyperventilation apnea,
we believe that an adequate dose of propofol is useful
in patients who frequently experience hyperventilation
syndrome.
The timing of drug usage for sustained hyperventila-
tion in the case of drugs that influence the occurrence
of apnea also needs discussion. The duration for whichcarbon dioxide rebreathing using a paper bag should be
attempted before further intervention should be deter-
mined. Treatment using a rebreathing bag for a prolonged
period may result in a decrease in oxygen content. In our
case, a cause of the desaturation (92%) might be related to
reducing the oxygen supply by inappropriate continuation
of rebreathing paper bag for a prolonged period of 15 mi-
nutes before the arrival of our team. Callaham et al. re-
vealed that the paper bag rebreathing method seems to be a
potentially risky procedure, because death, severe hypoxia
and collapse have been reported to occur with paper bag re-
breathing [7]. The need for sedative/anxiolytic drug therapy
in the early stages of hyperventilation should be considered,
even though sedative and anxiolytic agents have the poten-
tial to depress respiratory control. Another unanswered
question is the need for oxygen supplementation if desatur-
ation is observed during rebreathing therapy, and whether
the arterial PO2 level directly alters the compensatory re-
sponse to hyperventilation. Previous reports have suggested
that it might be desirable to provide a proper amount of
oxygen, because hypoxemia is detrimental for the brain and
hypoxemia during hypocapnia does not stimulate respir-
ation [1]. Our experience seems to indicate that respiratory
assistance using a bag and mask should be performed in
critical cases of post-hyperventilation apnea with hypoxemia
and loss of consciousness. It should be noted that most pa-
tients with post-hyperventilation apnea recover spontan-
eously in a short time without any treatment. Therefore, we
can wait for spontaneous recovery for some time without
the use of a bag-valve-mask under full monitoring of vital
signs related to cardio-respiratory function. However, as in-
dicated in a previous case report by Munemoto T et al. [1],
if prolonged post-hyperventilation apnea associated with se-
vere hypoxemia persists, as a precautionary measure it is
necessary to immediately perform respiratory assistance by
bag-valve-mask. Routine monitoring of SpO2 and other
vital signs, such as heart rate and blood pressure, should be
available for patients with hyperventilation syndrome.
Conclusion
We experienced a case of post-hyperventilation apnea
during dental treatment. Our experience suggests that
monitored anesthesia care with propofol may be effective
in the general management of patients with severe hyper-
ventilation attacks and post-hyperventilation apnea. This
case highlights the fact that proper emergency treatment
should be available for patients with hyperventilation syn-
drome who might develop post-hyperventilation apnea as-
sociated with hypoxemia and loss of consciousness.
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